4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-23-013496
Chief Operating Officer acquired 430,749 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-23 | Grant or award : show line 1 in the form | +36,722 | 36,722 | D |
| 2023-02-23 | Grant or award : show line 2 in the form | +394,027 | 394,027 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-23 | Grant or award : show line 3 in the form Employee Stock Option (right to buy) | +10,767 | 10,767 | D |
| 2023-02-23 | Grant or award : show line 4 in the form Employee Stock Option (right to buy) | +2,827 | 2,827 | D |
| 2023-02-23 | Grant or award : show line 5 in the form Employee Stock Option (right to buy) | +75,620 | 75,620 | D |
Loading xslF345X03/doc4.xml…